Timeline
Poolbeg Pharma wins South Africa patent for POLB 001 to 2038
Health & Bio Today: BSF Enterprise, Cizzle Biotechnology, Poolbeg Pharma, Istesso, Inspiration Healthcare
Poolbeg Pharma granted European patent for POLB 001 in CRS
Poolbeg activates first site for POLB 001 TOPICAL trial
Poolbeg presents POLB 001 preclinical data showing CRS reduction and potential AML benefit
Poolbeg to present POLB 001 CRS data at EHA
Poolbeg Pharma wins Canadian patent for POLB 001 CRS use
Poolbeg Pharma says TOPICAL trial gets greenlight
More in Telecoms
Vodafone Group shares soar after stake sale to Xavier Niel
French billionaire Xavier Niel is investing in Vodafone Group via his Vega entity, with funding provided entirely by Niel personally and financial institutions.